Skip to main content
74°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
155.44
-0.48 (-0.31%)
Streaming Delayed Price
Updated: 12:19 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
The S&P 500 Is in Correction Territory: 4 Surefire Stocks to Buy Right Now
March 17, 2025
Amazing deals abound within Wall Street's benchmark index.
Via
The Motley Fool
Topics
Stocks
Coinbase, Apple And Robinhood Are Among Top Large-Cap Losers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?
March 16, 2025
Large-cap stocks worst performers last week: TER, TTD, COIN, SAIL, GMAB, IBKR, DAL, ADBE, EXPE, HOOD, UAL, AAPL. Are they in your portfolio?
Via
Benzinga
Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
March 15, 2025
A lawsuit has been lodged against JPMorgan Chase by its employees, who claim that the company's prescription drug plan consented to pay exorbitant prices for medications.
Via
Benzinga
Topics
Lawsuit
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
March 10, 2025
Via
Benzinga
What 14 Analyst Ratings Have To Say About Johnson & Johnson
March 05, 2025
Via
Benzinga
What the Options Market Tells Us About Johnson & Johnson
March 03, 2025
Via
Benzinga
Kroger CEO Shake-Up
March 14, 2025
Via
The Motley Fool
Cool, Calm, and Collected: 2 Dividend ETFs to Buy During the S&P 500 Sell-Off
March 14, 2025
Via
The Motley Fool
Topics
ETFs
Stocks
Generate Passive Income From This Low-Cost Vanguard ETF That Is Crushing the S&P 500 in 2025
March 14, 2025
Via
The Motley Fool
Topics
ETFs
Stocks
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
March 14, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at branded pharmaceuticals stocks, starting...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
March 11, 2025
Via
Benzinga
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?
March 11, 2025
Vanguard has some excellent dividend ETFs, but they are right for different investors.
Via
The Motley Fool
Topics
ETFs
Are High-Yield Dividend Stocks Best For Income-Focused Investors?
March 11, 2025
When selecting dividend-paying stocks, one of the first things that investors look at is, of course, the annual yield. But are high-yield stocks always the best route for income-focused investors?...
Via
Talk Markets
Topics
Stocks / Equities
How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket
March 10, 2025
Via
Benzinga
2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger
March 10, 2025
Via
The Motley Fool
Why Is Protagonist Therapeutics Stock Trading Higher On Monday?
March 10, 2025
Protagonist and Johnson & Johnson's treatment for ulcerative colitis and psoriasis studies met key endpoints.
Via
Benzinga
Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out
March 10, 2025
The company is looking to take on Bristol Myers Squibb's Sotyktu in plaque psoriasis treatment.
Via
Investor's Business Daily
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
March 10, 2025
Via
Benzinga
3 Dividend Kings Shaking Off Market Woes
March 09, 2025
The market has thrown a tantrum over recent weeks following tariff news and other economic data pointing to a slowing consumer base. While it’s certainly been a turbulent period, several stocks have...
Via
Talk Markets
Topics
Stocks / Equities
World Trade
Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'
March 07, 2025
Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion
Via
Benzinga
ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug
March 06, 2025
HC Wainwright initiates coverage on ImmunityBio with a Buy rating, citing Anktiva's growth potential. The firm projects $4.3 billion in sales, up from $137M in 2025.
Via
Benzinga
Broaden Your ETF Exposure With These 3 Overlooked Funds
March 06, 2025
These ETFs have outperformed the market so far in 2025 but have lower asset bases than some of the most popular funds among investors.
Via
MarketBeat
Topics
ETFs
Economy
Government
2 Dow Stocks to Buy Hand Over Fist in March and 1 to Avoid
March 06, 2025
Two of the Dow Jones Industrial Average's 30 components make for no-brainer buys, while another brand-name member continues to suffer from self-inflicted wounds.
Via
The Motley Fool
Topics
Stocks
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 05, 2025
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations
March 04, 2025
From
Johnson & Johnson
Via
Business Wire
Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath
March 04, 2025
U.S. markets suffered a steep selloff Monday as President Donald Trump announced sweeping new tariffs, extending last week's losses and driving declines across all major sectors.
Via
Benzinga
Topics
Government
World Trade
Warren Buffett's State of the Market
March 03, 2025
Berkshire's cash hoard is approaching "Dr. Evil" levels.
Via
The Motley Fool
These Vanguard ETFs Show Where the Smart Money Is Moving Now
March 03, 2025
Via
The Motley Fool
Topics
ETFs
3 Top High-Yield Dividend Stocks I Plan to Buy in March for More Passive Income
March 02, 2025
Via
The Motley Fool
3 Dividend Stocks That Are No-Brainer Buys Right Now
March 01, 2025
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.